Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

FDA Offers Incentive For Prompt Responses To Inspections

This article was originally published in The Tan Sheet

Executive Summary

FDA's new enforcement strategy allows firms possibly to mitigate the severity of warning letters as an incentive for responding to inspection reports

You may also be interested in...



Office Of Regulatory Affairs Faces Training Challenges

Better funding for enforcement brings FDA's Office of Regulatory Affairs new challenges, including training an influx of investigators and adjusting to the retirement of more experienced staffers

Office Of Regulatory Affairs Faces Training Challenges

Better funding for enforcement brings FDA's Office of Regulatory Affairs new challenges, including training an influx of investigators and adjusting to the retirement of more experienced staffers

Office Of Regulatory Affairs Faces Training Challenges

Better funding for enforcement brings FDA's Office of Regulatory Affairs new challenges, including training an influx of investigators and adjusting to the retirement of more experienced staffers

Topics

Latest News
See All
UsernamePublicRestriction

Register

PS103229

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel